Literature DB >> 19904280

Understanding microRNAs in neurodegeneration.

Stephen M Eacker1, Ted M Dawson, Valina L Dawson.   

Abstract

Interest in the functions of microRNAs (miRNAs) in the nervous system has recently expanded to include their roles in neurodegeneration. Investigations have begun to reveal the influence of miRNAs on both neuronal survival and the accumulation of toxic proteins that are associated with neurodegeneration, and are providing clues as to how these toxic proteins can influence miRNA expression.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19904280      PMCID： PMC4120241          DOI： 10.1038/nrn2726

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN： 1471-003X            Impact factor:   34.870


  43 in total

1.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.

Authors:  Anne Rovelet-Lecrux; Didier Hannequin; Gregory Raux; Nathalie Le Meur; Annie Laquerrière; Anne Vital; Cécile Dumanchin; Sébastien Feuillette; Alexis Brice; Martine Vercelletto; Frédéric Dubas; Thierry Frebourg; Dominique Campion
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

2.  A brain-specific microRNA regulates dendritic spine development.

Authors:  Gerhard M Schratt; Fabian Tuebing; Elizabeth A Nigh; Christina G Kane; Mary E Sabatini; Michael Kiebler; Michael E Greenberg
Journal:  Nature       Date:  2006-01-19       Impact factor: 49.962

3.  Reciprocal actions of REST and a microRNA promote neuronal identity.

Authors:  Cecilia Conaco; Stefanie Otto; Jong-Jin Han; Gail Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

4.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

5.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration.

Authors:  Julide Bilen; Nan Liu; Barrington G Burnett; Randall N Pittman; Nancy M Bonini
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

6.  Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.

Authors:  Nathalie Brouwers; Kristel Sleegers; Sebastiaan Engelborghs; Veerle Bogaerts; Sally Serneels; Kenan Kamali; Ellen Corsmit; Evelyn De Leenheir; Jean-Jacques Martin; Peter P De Deyn; Christine Van Broeckhoven; Jessie Theuns
Journal:  Brain       Date:  2006-08-24       Impact factor: 13.501

7.  APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy.

Authors:  Kristel Sleegers; Nathalie Brouwers; Ilse Gijselinck; Jessie Theuns; Dirk Goossens; Jan Wauters; Jurgen Del-Favero; Marc Cruts; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Brain       Date:  2006-08-18       Impact factor: 13.501

8.  A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.

Authors:  Ngan Vo; Matthew E Klein; Olga Varlamova; David M Keller; Tadashi Yamamoto; Richard H Goodman; Soren Impey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

9.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

Authors:  Marie-Christine Chartier-Harlin; Jennifer Kachergus; Christophe Roumier; Vincent Mouroux; Xavier Douay; Sarah Lincoln; Clotilde Levecque; Lydie Larvor; Joris Andrieux; Mary Hulihan; Nawal Waucquier; Luc Defebvre; Philippe Amouyel; Matthew Farrer; Alain Destée
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

10.  Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.

Authors:  Hardy J Rideout; Paula Dietrich; Magali Savalle; William T Dauer; Leonidas Stefanis
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372
View more
  133 in total

1.  Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2.

Authors:  Yu Miyazaki; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Yue-Mei Jiang; Zhe Huang; Hideki Doi; Shinjiro Matsumoto; Naohide Kondo; Madoka Iida; Genki Tohnai; Fumiaki Tanaka; Shin-ichi Muramatsu; Gen Sobue
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  MiR-219 Protects Against Seizure in the Kainic Acid Model of Epilepsy.

Authors:  Honghua Zheng; Rong Tang; Yi Yao; Zhilin Ji; Yuanyuan Cao; Zhaoji Liu; Feng Peng; Wenjie Wang; Dan Can; Huiqin Xing; Guojun Bu; Huaxi Xu; Yun-Wu Zhang; Weihong Zheng
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

Review 3.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

4.  Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury.

Authors:  Ke-Jie Yin; Zhen Deng; Milton Hamblin; Yi Xiang; Huarong Huang; Jifeng Zhang; Xiaodan Jiang; Yanzhuang Wang; Y Eugene Chen
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 5.  MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.

Authors:  Patrick Provost
Journal:  Brain Res       Date:  2010-03-27       Impact factor: 3.252

Review 6.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

7.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

8.  Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.

Authors:  Ross C McKiernan; Eva M Jimenez-Mateos; Takanori Sano; Isabella Bray; Raymond L Stallings; Roger P Simon; David C Henshall
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

Review 9.  Progress and perspectives of neural tissue engineering.

Authors:  Xiaosong Gu
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

10.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.